Cardiac Resynchronization Therapy in the Cardiorenal Syndrome | Zendy

Margot K. Davis | Zendy; Sean Virani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiac Resynchronization Therapy in the Cardiorenal Syndrome

Author(s) -

Margot K. Davis,

Sean Virani

Publication year - 2011

Publication title -

international journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.551

H-Index - 29

eISSN - 2090-2158

pISSN - 2090-214X

DOI - 10.4061/2011/168461

Subject(s) - cardiorenal syndrome , medicine , cardiac resynchronization therapy , heart failure , cardiology , renal function , population , intensive care medicine , cardiac function curve , ejection fraction , environmental health

The cardiorenal syndrome (CRS) is a complex clinical syndrome in which dysfunction of either the heart or the kidneys affects the functioning of the other organ system. Many therapies used in heart failure have further detrimental effects on renal function. Cardiac resynchronization therapy (CRT) is a relatively new form of device therapy that reduces morbidity and mortality in patients with heart failure. This review will discuss the effects of CRT on renal function in patients with CRS, the impact of baseline renal function on response to CRT, and potential risks associated with CRT in this unique population

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research